NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 134 filers reported holding NEOGENOMICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $270,465 | -11.8% | 19,500 | 0.0% | 0.05% | -13.8% |
| Q1 2024 | $306,540 | -2.8% | 19,500 | 0.0% | 0.06% | -12.1% |
| Q4 2023 | $315,510 | +31.5% | 19,500 | 0.0% | 0.07% | +17.9% |
| Q3 2023 | $239,850 | -23.5% | 19,500 | 0.0% | 0.06% | -22.2% |
| Q2 2023 | $313,365 | -7.7% | 19,500 | 0.0% | 0.07% | -15.3% |
| Q1 2023 | $339,495 | +88.4% | 19,500 | 0.0% | 0.08% | +73.5% |
| Q4 2022 | $180,180 | +7.3% | 19,500 | 0.0% | 0.05% | 0.0% |
| Q3 2022 | $167,895 | +5.6% | 19,500 | 0.0% | 0.05% | +14.0% |
| Q2 2022 | $158,925 | -32.9% | 19,500 | 0.0% | 0.04% | -30.6% |
| Q1 2022 | $236,925 | -64.4% | 19,500 | 0.0% | 0.06% | -64.2% |
| Q4 2021 | $665,340 | -42.9% | 19,500 | -19.3% | 0.17% | -48.7% |
| Q3 2021 | $1,166,202 | +24.9% | 24,175 | +16.9% | 0.34% | +16.2% |
| Q2 2021 | $933,890 | -6.3% | 20,675 | 0.0% | 0.29% | -16.7% |
| Q1 2021 | $997,155 | -10.6% | 20,675 | -0.2% | 0.35% | -20.7% |
| Q4 2020 | $1,115,834 | +45.9% | 20,725 | 0.0% | 0.44% | +28.0% |
| Q3 2020 | $764,545 | +19.1% | 20,725 | 0.0% | 0.34% | +3.9% |
| Q2 2020 | $642,061 | +12.2% | 20,725 | 0.0% | 0.33% | -17.7% |
| Q1 2020 | $572,217 | -5.6% | 20,725 | 0.0% | 0.40% | +23.8% |
| Q4 2019 | $606,206 | +54.8% | 20,725 | +1.2% | 0.32% | +25.1% |
| Q3 2019 | $391,482 | -11.9% | 20,475 | +1.1% | 0.26% | -14.8% |
| Q2 2019 | $444,285 | +7.2% | 20,250 | 0.0% | 0.30% | +1.0% |
| Q1 2019 | $414,315 | +62.3% | 20,250 | 0.0% | 0.30% | +40.0% |
| Q4 2018 | $255,353 | -17.9% | 20,250 | 0.0% | 0.22% | -3.2% |
| Q3 2018 | $310,838 | +16.5% | 20,250 | -0.5% | 0.22% | +6.2% |
| Q2 2018 | $266,789 | +60.7% | 20,350 | 0.0% | 0.21% | +52.6% |
| Q1 2018 | $166,056 | -7.9% | 20,350 | 0.0% | 0.14% | -12.7% |
| Q4 2017 | $180,301 | -20.4% | 20,350 | 0.0% | 0.16% | -25.9% |
| Q3 2017 | $226,496 | +24.2% | 20,350 | 0.0% | 0.21% | +45.2% |
| Q2 2017 | $182,336 | +13.6% | 20,350 | 0.0% | 0.15% | +5.8% |
| Q1 2017 | $160,562 | -7.9% | 20,350 | 0.0% | 0.14% | -12.1% |
| Q4 2016 | $174,400 | – | 20,350 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,615,513 | $13,166,000 | 9.25% |
| First Light Asset Management, LLC | 2,715,487 | $22,131,000 | 2.58% |
| PERKINS CAPITAL MANAGEMENT INC | 202,550 | $1,651,000 | 1.71% |
| Greenhouse Funds LLLP | 1,395,035 | $11,370,000 | 1.25% |
| EMERALD ADVISERS, LLC | 1,213,353 | $9,889,000 | 0.51% |
| Bullseye Asset Management LLC | 108,272 | $883,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 959,858 | $7,823,000 | 0.45% |
| OAK FAMILY ADVISORS, LLC | 88,604 | $722,000 | 0.36% |
| MPM BioImpact LLC | 135,573 | $1,105,000 | 0.31% |
| Fernwood Investment Management, LLC | 70,285 | $573,000 | 0.25% |